Osteoarthritis Cum Laude

P-16.1.1 - Prospective Comparison of Sham vs. Placebo Injections: Data from a Trial of Lorecivivint, a Wnt Pathway Inhibitor for Knee Osteoarthritis

Corresponding Author
Award
Cum Laude
Presentation Topic
Osteoarthritis
Poster Rating
 |